STADA

  1. STADA Repurchases Rights for Ladival

    STADA Repurchases Rights for Ladival

    CEO Claudio Albrecht: “Another important step in the internationalization of our brand portfolio.”

    Press Release

  2. Strategic expansion of OTC portfolio continues

    Strategic expansion of OTC portfolio continues

    STADA acquires EMEA rights to global anti-dandruff brand Nizoral from Janssen Pharmaceutica

    Press Release

  3. STADA recovers top-selling product

    STADA recovers top-selling product

    Distribution of Parkinson's medication in Germany and Scandinavia in the future

    Press Release

  4. Quality at STADA

    Quality at STADA

    Quality and responsibility to all who use our products or services is a fundamental part of our corporate strategy.

    Learn more

Company

Company

STADA – a publicly traded, international company with a focus on the healthcare market.

Learn more

STADA-EURO-Bond 2015/2022

STADA-EURO-Bond 2015/2022

In this area you can find information on the invitation to the Bondholders‘ Meeting on July 17, 2018 and the Tender Offer.

Learn more

Interview

Interview

CEO Dr. Claudio Albrecht on the new strategy: "More focused and aggressive"
Learn more


STADA Generics


What are generics?

What are generics?

One of STADA's important business areas is the production and sales of inexpensive medicines that are generally known as generics.

Learn more

Products


STADA Branded Products

STADA Branded Products

A strong brand with strong brands

Learn more

Career at STADA

Career at STADA

STADA's employees, with their extensive expertise, their experience and their strong commitment, play an important part in the longstanding success of the Group.

Learn more

Investor Relations

Investor Relations

Here you can find all the facts and background information about the STADA securities.

Lern more

Sustainability

Sustainability

For STADA "All the best" means taking responsibility.

Learn more

entdecken